Department of Neuroscience, Biomedicine and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.
Department of Neuroscience, Biomedicine and Movement Sciences, Biological Chemistry Section, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.
Int J Biol Macromol. 2021 Nov 30;191:560-571. doi: 10.1016/j.ijbiomac.2021.09.095. Epub 2021 Sep 24.
Onconase (ONC) is a monomeric amphibian "pancreatic-type" RNase endowed with remarkable anticancer activity. ONC spontaneously forms traces of a dimer (ONC-D) in solution, while larger amounts can be formed when ONC is lyophilized from mildly acidic solutions. Here, we report the crystal structure of ONC-D and analyze its catalytic and antitumor activities in comparison to ONC. ONC-D forms via the three-dimensional swapping of the N-terminal α-helix between two monomers, but it displays a significantly different quaternary structure from that previously modeled [Fagagnini A et al., 2017, Biochem J 474, 3767-81], and based on the crystal structure of the RNase A N-terminal swapped dimer. ONC-D presents a variable quaternary assembly deriving from a variable open interface, while it retains a catalytic activity that is similar to that of ONC. Notably, ONC-D displays antitumor activity against two human melanoma cell lines, although it exerts a slightly lower cytostatic effect than the monomer. The inhibition of melanoma cell proliferation by ONC or ONC-D is associated with the reduction of the expression of the anti-apoptotic B cell lymphoma 2 (Bcl2), as well as of the total expression and phosphorylation of the Signal Transducer and Activator of Transcription (STAT)-3. Phosphorylation is inhibited in both STAT3 Tyr705 and Ser727 key-residues, as well as in its upstream tyrosine-kinase Src. Consequently, both ONC species should exert their anti-cancer action by inhibiting the pro-tumor pleiotropic STAT3 effects deriving either by its phospho-tyrosine activation or by its non-canonical signaling pathways. Both ONC species, indeed, increase the portion of A375 cells undergoing apoptotic cell death. This study expands the variety of RNase domain-swapped dimeric structures, underlining the unpredictability of the open interface arrangement upon domain swapping. Structural data also offer valuable insights to analyze the differences in the measured ONC or ONC-D biological activities.
ONC 是一种单体两栖“胰腺型”RNase,具有显著的抗癌活性。ONC 在溶液中自发形成痕量二聚体(ONC-D),而当 ONC 从微酸性溶液中冻干时,可形成更多的二聚体。在这里,我们报告了 ONC-D 的晶体结构,并分析了其与 ONC 相比的催化和抗肿瘤活性。ONC-D 通过两个单体之间的三维交换形成,但是其四级结构与之前建模的结构[Fagagnini A 等人,2017,生物化学杂志 474,3767-81]显著不同,并且基于 RNase A N 端交换二聚体的晶体结构。ONC-D 呈现出可变的四级组装,源于可变的开放界面,同时保持与 ONC 相似的催化活性。值得注意的是,ONC-D 对两种人黑色素瘤细胞系具有抗肿瘤活性,尽管其细胞抑制作用略低于单体。ONC 或 ONC-D 抑制黑色素瘤细胞增殖与抗凋亡 B 细胞淋巴瘤 2(Bcl2)的表达减少以及信号转导和转录激活剂 3(STAT3)的总表达和磷酸化有关。STAT3 Tyr705 和 Ser727 关键残基以及其上游酪氨酸激酶Src 的磷酸化均受到抑制。因此,两种 ONC 物质都应该通过抑制源自其磷酸酪氨酸激活或非典型信号通路的促肿瘤多效性 STAT3 效应来发挥其抗癌作用。两种 ONC 物质确实都增加了 A375 细胞经历凋亡细胞死亡的比例。本研究扩展了 RNase 结构域交换二聚体结构的多样性,强调了结构域交换时开放界面排列的不可预测性。结构数据还为分析测量的 ONC 或 ONC-D 生物学活性的差异提供了有价值的见解。